Elsevier

Life Sciences

Volume 257, 15 September 2020, 118059
Life Sciences

Far-reaching advances in the role of carbon nanotubes in cancer therapy

https://doi.org/10.1016/j.lfs.2020.118059Get rights and content

Abstract

Cancer includes a group of diseases involving unregulated cell growth with the potential to invade or expand to other parts of the body, resulting in an estimate of 9.6 million deaths worldwide in 2018. Manifold studies have been conducted to design more efficacious techniques for cancer therapy due to the inadequacy of conventional treatments including chemotherapy, surgery, and radiation therapy. With the advances in the biomedical applications of nanotechnology-based systems, nanomaterials have gained increasing attention as promising vehicles for targeted cancer therapy and optimizing treatment outcomes. Owing to their outstanding thermal, electrical, optical and chemical properties, carbon nanotubes (CNTs) have been profoundly studied to explore the various perspectives of their application in cancer treatment. The current study aims to review the role of CNTs whether as a carrier or mediator in cancer treatment for enhancing the efficacy as well as the specificity of therapy and reducing adverse side effects. This comprehensive review indicates that CNTs have the capability to be the next generation nanomaterials to actualize noninvasive targeted eradication of tumors. However, further studies are needed to evaluate the consequences of their biomedical application before the transition into clinical trials, since possible adverse effects of CNTs on biological systems have not been clearly understood.

Introduction

Cancer includes a group of diseases involving unregulated cell growth with the potential to invade or expand to other parts of the body resulting in an estimate of 9.6 million deaths worldwide in 2018 [1]. Although numerous studies have been conducted to design new strategies for efficient cancer therapy, adjustment of cancer-related morbidity and mortality to an optimal level has not been achieved. The intrinsic shortcomings of conventional cancer treatment options such as surgical intervention, chemotherapy, and radiation therapy cause to rise the emergence of nanotechnology-based systems as a promising strategy for optimizing cancer therapy success by benefiting from the advantages and particular properties of nanoparticles for drug delivery, diagnosis, and imaging [2,3]. The unique properties such as high drug loading capacity and target site accumulation of nanomaterials such as liposomes, nanofibers, protein-based nanostructures, and inorganic nanoparticles introduced them as suitable carriers for overcoming biological barriers and pharmacokinetic obstacles like inadequate access of drugs to pathological sites, drug resistance at the cellular level, drug resistance at tumor microenvironment level, inefficient eradication of cancer stem cells and lack of specificity, in comparison to use of pristine anticancer drugs and traditional drug delivery systems [4,5].

Inorganic nanoparticles such as metal oxides, gold, and carbon-based nanomaterials, have gained increasing attention during the last decade as potential carriers for diagnostics and therapeutics of various cancers [[6], [7], [8], [9], [10], [11], [12], [13]]. Among inorganic nanoparticles, carbon nanotubes (CNTs) have been developed due to their exclusive physicochemical properties and high capability of binding to several materials including anticancer drugs, proteins, genes, etc. [14]. Single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) are the two types of CNTs with a broad range of features and functions have been extensively studied to explore the various perspectives of their application in cancer treatment. CNTs can be classified as mediators and nano-carriers for targeted cancer therapy [14]. In spite of expansive studies since their discovery, CNTs and their potential novel applications remain a hot topic for researchers in different disciplines. The aim of this study was to review the performance of SWCNTs and MWCNTs in cancer therapy either as a mediator or carrier, analyze the structure and mechanism of CNTs-based complex and their impact on several cancer cell lines both in-vitro and in vivo situation.

To review the effect of CNTs on cancer therapy, 8 main keywords including “carbon nanotubes”, “single-walled carbon nanotube”, “multi-walled carbon nanotubes”, “cancer treatment/therapy”, “cancer cell line” and “In vivo effect of CNTs on cancers” have been searched to found the relevant articles for 30 days. Over 500 articles were retrieved which were published from inception to June 2020. The search was narrowed to cover only the therapeutic effects of CNTs on cancers and the rest articles were removed from the references.

Section snippets

CNTs as a member of carbon nanomaterials family

Carbon-based nanomaterials are more becoming attractive day after day for biological application due to the essence of diverse carbon allotropes, such as amorphous carbon, graphite, diamonds, CNTs, graphene oxide, carbon quantum dots and fullerene. Each of the carbon-based nanostructures display unbeatable characteristics and has been largely exploited in multiple biomedical applications including drug delivery [15]. However, among several carbon-based nanomaterials, graphite and its

Biocompatibility of CNTs

CNTs are heterogeneous nanomaterials with diverse physicochemical properties that can promote the unfavorable biological and pharmacological effects. Therefore, the compatibility of CNTs with biological systems is an obstacle to the realization of their application for medical purposes. Several issues such as uncontrollable agglomeration of pristine CNTs, incompatibility with biological medium, potential adverse effects, immunogenicity, cellular toxicity, organ accumulation and biopersistence

Surface modification/functionalization of CNTs

CNTs tend to agglomerate uncontrollably due to van der Waals forces among bundles and high surface energy. This hinders their dispersion in almost all organic and inorganic solvents. The poor dispensability and insolubility of CNTs have limited their use in biomedical applications. Therefore, the efficient application of CNTs needs the significant chemical modifications for improving their compatibility with host materials [32]. Furthermore, there is a relationship between blood circulation

Protein corona of CNTs

Due to their high surface area, CNTs can interact with variety of biomolecules through charge complementary, π–π stacking or hydrophobic interactions to form a dynamic composition, when administered in vivo, the most common phenomenon is related to adsorption of proteins from plasma and/or intracellular fluid on the surface of these nanomaterials [48] either by diffusion, or by moving down a potential energy gradient to reduce their surface energy [49] which results in the formation of a layer,

Cellular toxicity of CNTs in normal and cancer cells

Although the cellular toxicity of CNTs are highly dependent of heterogeneity of cell lines used for in cytotoxicity assessment [68], they have demonstrated their ability to reduce the cell viability in both malignant cells [69] and normal cells through various mechanisms [60]. In general, prior studies have confirmed that CNTs could inhibit cell proliferation and promote cell death in several ways. Overall, CNTs can induce membrane destabilization, reduce cell adherence ability, derive

In vivo adverse effects of CNTs

CNTs induced adverse effects have been one of the major concerns of their usage in biomedical area. CNTs might fit the fiber pathogenicity pattern resembling other high aspect ratio fibrous nanomaterials particularly asbestos [98]. To boot, as previously mentioned, CNTs can demonstrate cytotoxicity effects on cells in different levels through various mechanisms depending on certain traits. Therefore they can cause harmful adverse events in the case of infecting the normal cells. Also, CNTs

Pharmacokinetics of CNTs

The bioactivity of any xenobiotic biological system depends on the rate and extent of their absorption, distribution, metabolism, and elimination (ADME). CNT-complexes are generally administered intravenously when used for cancer therapy leading to rapid delivery and distribution all through the vasculature. Therefore, systemic absorption of these nanomaterials is not a crucial matter in their biomedical application for cancer treatment. While, distribution of CNTs in biological environment

CNTs-based modalities in cancer treatments

The unique properties of CNTs such as high loading capacity and stability of CNTs in binding to various chemicals and biological molecules, large surface area, small size and efficient cellular internalization as well as their ability to be chemically and physically modified, have made them suitable candidates as delivery vehicles for therapeutic and diagnostic agents in various diseases, especially in cancer. Moreover, their strong optical absorption in the Near-Infrared (NIR) biological

Conclusion

In this review, we summarized the promises, facts and limitations of developing more efficacious treatment strategies for cancer based on single- and multi-walled carbon nanotubes. The great efforts have been invested by numerous researchers to explore the potential contributions of CNTs in cancer treatment. It has been clearly shown that there is notable potential for CNTs to enhance cancer therapy outcomes. The unique properties of CNTs such as their amendable physicochemical properties, high

Funding source

None.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References (234)

  • Q. Zhang et al.

    Advanced review of graphene-based nanomaterials in drug delivery systems: synthesis, modification, toxicity and application

    Mater. Sci. Eng. C

    (2017)
  • B. Zhang et al.

    Interactions of graphene with mammalian cells: molecular mechanisms and biomedical insights

    Adv. Drug Deliv. Rev.

    (2016)
  • M. Joshi et al.

    Aminated carbon-based “cargo vehicles” for improved delivery of methotrexate to breast cancer cells

    Mater. Sci. Eng. C

    (2017)
  • V. Khabashesku et al.

    Chemical modification of carbon nanotubes

    Mendeleev Communications

    (2006)
  • M. Foldvari et al.

    Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues

    Nanomedicine

    (2008)
  • Y. Zhang et al.

    Functionalized carbon nanotubes for potential medicinal applications

    Drug Discov. Today

    (2010)
  • L. Lacerda et al.

    Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes

    Biomaterials

    (2012)
  • C. Klumpp et al.

    Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics

    Biochimica et Biophysica Acta (BBA)-Biomembranes

    (2006)
  • A.G. Kidane et al.

    A novel nanocomposite polymer for development of synthetic heart valve leaflets

    Acta Biomater.

    (2009)
  • A.K. Singh

    Chapter 6 - nanoparticle pharmacokinetics and toxicokinetics

  • S. Lanone et al.

    Determinants of carbon nanotube toxicity

    Adv. Drug Deliv. Rev.

    (2013)
  • S.H. De Paoli et al.

    The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets

    Biomaterials

    (2014)
  • C. Salvador-Morales et al.

    Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms

    Carbon

    (2007)
  • A. Krais et al.

    Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum

    Nanomedicine

    (2014)
  • X. Cai et al.

    Characterization of carbon nanotube protein corona by using quantitative proteomics

    Nanomedicine

    (2013)
  • V. Kagan et al.

    Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron

    Toxicol. Lett.

    (2006)
  • N.A. Monteiro-Riviere et al.

    Multi-walled carbon nanotube interactions with human epidermal keratinocytes

    Toxicol. Lett.

    (2005)
  • M. Bottini et al.

    Multi-walled carbon nanotubes induce T lymphocyte apoptosis

    Toxicol. Lett.

    (2006)
  • L.Y. Hu et al.

    ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats

    Neuroscience

    (2010)
  • D. Elgrabli et al.

    Induction of apoptosis and absence of inflammation in rat lung after intratracheal instillation of multiwalled carbon nanotubes

    Toxicology

    (2008)
  • M.L. Di Giorgio et al.

    Effects of single and multi walled carbon nanotubes on macrophages: cyto and genotoxicity and electron microscopy

    Mutation Research/Genetic Toxicology and Environmental Mutagenesis

    (2011)
  • X. Wang et al.

    Multi-walled carbon nanotubes induce apoptosis via mitochondrial pathway and scavenger receptor

    Toxicol. in Vitro

    (2012)
  • L. Zhou et al.

    Multi-walled carbon nanotubes: a cytotoxicity study in relation to functionalization, dose and dispersion

    Toxicol. in Vitro

    (2017)
  • A. Chowdhry et al.

    Characterization of functionalized multiwalled carbon nanotubes and comparison of their cellular toxicity between HEK 293 cells and zebra fish in vivo

    Heliyon

    (2019)
  • A.B. Kane et al.

    The asbestos-carbon nanotube analogy: an update

    Toxicol. Appl. Pharmacol.

    (2018)
  • H. Dumortier

    When carbon nanotubes encounter the immune system: desirable and undesirable effects

    Adv. Drug Deliv. Rev.

    (2013)
  • A.J. Andersen et al.

    Perspectives on carbon nanotube-mediated adverse immune effects

    Adv. Drug Deliv. Rev.

    (2012)
  • E.J. Park et al.

    Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation

    Toxicology

    (2009)
  • B. Cao et al.

    The global cancer burden

  • E. Blanco et al.

    Principles of nanoparticle design for overcoming biological barriers to drug delivery

    Nat. Biotechnol.

    (2015)
  • M.H. Jouybari et al.

    Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro

    Colloids Surf. B: Biointerfaces

    (2019)
  • L. Hosseini et al.

    Fabrication of PLA/MWCNT/Fe3O4 composite nanofibers for leukemia cancer cells

    Int. J. Polym. Mater. Polym. Biomater.

    (2016)
  • K.H. Son et al.

    Carbon nanotubes as cancer therapeutic carriers and mediators

    Int. J. Nanomedicine

    (2016)
  • Z. Ming et al.

    Toxicity of pristine and chemically functionalized fullerenes to white rot fungus Phanerochaete Chrysosporium

    Nanomaterials

    (2018)
  • Z. Xue et al.

    Graphene quantum dot assisted translocation of drugs into a cell membrane

    Nanoscale

    (2019)
  • M. Rezaian et al.

    pH-sensitive co-adsorption/release of doxorubicin and paclitaxel by carbon nanotube, fullerene, and graphene oxide in combination with N-isopropylacrylamide: a molecular dynamics study

    Biomolecules

    (2018)
  • P. Unwin et al.

    Nanoscale electrochemistry of sp2 carbon materials: from graphite and graphene to carbon nanotubes

    Acc. Chem. Res.

    (2016)
  • S. Iijima et al.

    Single-shell carbon nanotubes of 1-nm diameter

    nature

    (1993)
  • R. Zhang et al.

    Growth of half-meter long carbon nanotubes based on Schulz–Flory distribution

    ACS Nano

    (2013)
  • A. Kis et al.

    Nanomechanics of carbon nanotubes

    Philos. Trans. R. Soc. A Math. Phys. Eng. Sci.

    (2008)
  • Cited by (0)

    View full text